ALT5 Sigma Corp 2026年季度报告

FORM 10-Q ☒Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the quarterly period ended September27, 2025 or Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Commission File No. 0-19621 ALT5 SIGMA CORPORATION(Exact name of registrant as specified in its charter) 89113(Zip Code) 702-997-5968(Registrant’s telephone number, including area code) Securities registered pursuant to Section 12(b) of the Act: The Nasdaq Stock Market LLC(The Nasdaq Capital Market) Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities ExchangeAct of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports) and (2) has beensubject to such filing requirements for the past 90 days.YesNo Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant toRule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).YesNo Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reportingcompany, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,”and “emerging growth company” in Rule 12b-2 of the Exchange Act. (Check one) Large accelerated filerNon-accelerated filerEmerging growth company If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complyingwith any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act).YesNo As of January12, 2025, there were 126,199,169 outstanding shares of the registrant’s common stock, with a par value of $0.001. ALT5 SIGMA CORPORATION INDEX TO FORM 10-Q Item 1.Condensed Consolidated Financial Statements3Unaudited Condensed Consolidated Balance Sheets as ofSeptember 27, 2025 and December 28, 20243Unaudited Condensed Consolidated Statements of Operations and Comprehensive Income for the 13 and 39weeks endedSeptember 27, 2025 and June 29, 20245Unaudited Condensed Consolidated Statements of Cash Flows for the 39 weeks endedSeptember 27, 2025 andJune 29, 20246Unaudited Condensed Consolidated Statements of Stockholders’ Equity for the 13 and 39 weeks endedSeptember 27, 2025 and June 29, 20248Notes to Unaudited Condensed Consolidated Financial Statements11Item 2.Management’s Discussion and Analysis of Financial Condition and Results of Operations42Item 3.Quantitative and Qualitative Disclosures About Market Risk51Item 4.Controls and Procedures51PART II. OTHER INFORMATIONItem 1.Legal Proceedings53Item 1A.Risk Factors53Item 2.Unregistered Sales of Equity Securities and Use of Proceeds53Item 3.Defaults Upon Senior Securities53Item 4.Mine Safety Disclosures53Item 5Other Information53Item 6.Exhibits53SIGNATURES56 PART I. FINANCIAL INFORMATION ITEM 1. Condensed Consolidated Financial Statements ALT5 SIGMA CORPORATIONCONDENSED CONSOLIDATED BALANCE SHEETS(Dollars in thousands, except per-share amounts) ALT5 SIGMA CORPORATIONCONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS(UNAUDITED)(In thousands) ALT5 SIGMA CORPORATIONCONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY(UNAUDITED)(Dollars in thousands) Note 1: Background The accompanying consolidated financial statements include the accounts of ALT5 Sigma Corporation, a Nevada corporation, and itssubsidiaries (collectively, the “Company” or “ALT5”). Effective July 15, 2024, the Company changed its corporate name from “JanOneInc.” to “ALT5 Sigma Corporation,” and also changed its Nasdaq common stock ticker symbol from “JAN” to “ALTS”. The corporatename change was effected through a parent/subsidiary short-form merger of ALT5 Sigma Corporation, the Company’s wholly-ownedNevada subsidiary formed solely for the purpose of effectuating the name change), whereby it merged with and into the Company, with theCompany being the surviving entity, albeit with its new name. The Company had three operating segments – Fintech, Biotechnology, and Corporate and Other. In connection with a partial or completespinoff of its subsidiary, Alyea Therapeutics Corporation (“Alyea”), the accounts for the Biotechnology segment have been presented asdiscontinued operations in the accompanying consolidated financial statements. Fintech On May 15, 2024, the Company acquired ALT5 Sigma, Inc. (“ALT5 Subsidiary”). ALT5 Subsidiary is a fintech company that provides nextgeneration blockchain-powered technologies to enable a migration to a new global financial paradigm. ALT5 Subsidiary, through itsrespective subsidiar